Vienna Institute For Research In Ocular Surgery
Clinical trials sponsored by Vienna Institute For Research In Ocular Surgery, explained in plain language.
-
Can a stronger dose of eye injections keep vision stable longer?
Disease control OngoingThis study looks at whether switching people with wet age-related macular degeneration (AMD) from the standard 2mg dose of Aflibercept to a higher 8mg dose can allow longer breaks between eye injections while still keeping vision stable. About 50 adults who have already had at le…
Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Diabetes drug metformin may slow cataract cell growth
Knowledge-focused OngoingThis pilot study looks at how the diabetes drug metformin reaches the lens of the eye and whether it can slow the growth of lens cells in the lab. Researchers will measure metformin levels in lens capsules and blood from 40 diabetic patients having cataract surgery. The goal is t…
Phase: NA • Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC